Dr. Mell on Individualizing Treatment for Head and Neck Cancer

Loren K. Mell, MD
Published: Friday, Mar 23, 2018



Loren K. Mell, MD, assistant professor, Department of Radiation Medicine and Applied Sciences, University of California, San Diego School of Medicine, discusses individualizing treatments for patients with head and neck cancer.

Mell says that investigators are making efforts to individualize care within the context of evidence-based medicine. These are inherently in conflict with one another, he explains.

With the introduction of immunotherapy, there is a different paradigm for cancer treatment, as it offers some appealing options, says Mell. This is especially true for treating older patients whose immune functions are in decline. It is a topic that is being revisited, Mell explains, and research is ongoing.
SELECTED
LANGUAGE


Loren K. Mell, MD, assistant professor, Department of Radiation Medicine and Applied Sciences, University of California, San Diego School of Medicine, discusses individualizing treatments for patients with head and neck cancer.

Mell says that investigators are making efforts to individualize care within the context of evidence-based medicine. These are inherently in conflict with one another, he explains.

With the introduction of immunotherapy, there is a different paradigm for cancer treatment, as it offers some appealing options, says Mell. This is especially true for treating older patients whose immune functions are in decline. It is a topic that is being revisited, Mell explains, and research is ongoing.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
Publication Bottom Border
Border Publication
x